Trial
NCT01004419
Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Wisconsin, Madison
Collaborators
AstraZeneca; University of Pittsburgh
Condition
Carcinoma, Non Small Cell Lung
Intervention
ZD6474 (vandetanib)
Why stopped
Support for investigational products has been withdrawn.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-02